OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting Antigens for Universal Influenza Vaccine Development
Quyen Thi Nguyen, Young Ki Choi
Viruses (2021) Vol. 13, Iss. 6, pp. 973-973
Open Access | Times Cited: 26
Quyen Thi Nguyen, Young Ki Choi
Viruses (2021) Vol. 13, Iss. 6, pp. 973-973
Open Access | Times Cited: 26
Showing 1-25 of 26 citing articles:
Lipid Nanoparticle Delivery Systems to Enable mRNA-Based Therapeutics
Sean C. Semple, Robert D. Leone, Christopher Barbosa, et al.
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 398-398
Open Access | Times Cited: 49
Sean C. Semple, Robert D. Leone, Christopher Barbosa, et al.
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 398-398
Open Access | Times Cited: 49
In Silico Epitope-Based Peptide Vaccine Design Against Influenza B Virus: An Immunoinformatics Approach
Hao Wu, Chenyan Zhao, Ziqi Cheng, et al.
Processes (2025) Vol. 13, Iss. 3, pp. 681-681
Open Access
Hao Wu, Chenyan Zhao, Ziqi Cheng, et al.
Processes (2025) Vol. 13, Iss. 3, pp. 681-681
Open Access
A novel tetravalent influenza vaccine based on one chimpanzee adenoviral vector
Yixin Niu, Yao Yan, Ying Hu, et al.
Vaccine (2025) Vol. 53, pp. 126959-126959
Closed Access
Yixin Niu, Yao Yan, Ying Hu, et al.
Vaccine (2025) Vol. 53, pp. 126959-126959
Closed Access
Revisiting the dimensions of universal vaccine with special focus on COVID-19: Efficacy versus methods of designing
Puja Jaishwal, Kisalay Jha, Satarudra Prakash Singh
International Journal of Biological Macromolecules (2024) Vol. 277, pp. 134012-134012
Closed Access | Times Cited: 3
Puja Jaishwal, Kisalay Jha, Satarudra Prakash Singh
International Journal of Biological Macromolecules (2024) Vol. 277, pp. 134012-134012
Closed Access | Times Cited: 3
Recent Progress in Recombinant Influenza Vaccine Development Toward Heterosubtypic Immune Response
Mark B. Carascal, Rance Derrick N. Pavon, Windell L. Rivera
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
Mark B. Carascal, Rance Derrick N. Pavon, Windell L. Rivera
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
A biepitope, adjuvant-free, self-assembled influenza nanovaccine provides cross-protection against H3N2 and H1N1 viruses in mice
Yongbo Qiao, YaXin Zhang, Jie Chen, et al.
Nano Research (2022) Vol. 15, Iss. 9, pp. 8304-8314
Open Access | Times Cited: 12
Yongbo Qiao, YaXin Zhang, Jie Chen, et al.
Nano Research (2022) Vol. 15, Iss. 9, pp. 8304-8314
Open Access | Times Cited: 12
R-DOTAP Cationic Lipid Nanoparticles Outperform Squalene-Based Adjuvant Systems in Elicitation of CD4 T Cells after Recombinant Influenza Hemagglutinin Vaccination
Thomas R Henson, Katherine A. Richards, Siva K. Gandhapudi, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 538-538
Open Access | Times Cited: 6
Thomas R Henson, Katherine A. Richards, Siva K. Gandhapudi, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 538-538
Open Access | Times Cited: 6
Self‐Assembled Multiepitope Nanovaccine Provides Long‐Lasting Cross‐Protection against Influenza Virus
Jiaojiao Nie, Qingyu Wang, Chenxi Li, et al.
Advanced Healthcare Materials (2023) Vol. 13, Iss. 10
Closed Access | Times Cited: 5
Jiaojiao Nie, Qingyu Wang, Chenxi Li, et al.
Advanced Healthcare Materials (2023) Vol. 13, Iss. 10
Closed Access | Times Cited: 5
Targeting H3N2 Influenza: Advancements in Treatment and Vaccine Strategies
Shriyansh Srivastava, Nandani Jayaswal, Sachin Kumar, et al.
(2024)
Open Access | Times Cited: 1
Shriyansh Srivastava, Nandani Jayaswal, Sachin Kumar, et al.
(2024)
Open Access | Times Cited: 1
Generation of Broad Protection against Influenza with Di-Tyrosine-Cross-Linked M2e Nanoclusters
Logan R. Wilks, Gaurav Joshi, Natalie Rychener, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 5, pp. 1552-1560
Closed Access | Times Cited: 1
Logan R. Wilks, Gaurav Joshi, Natalie Rychener, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 5, pp. 1552-1560
Closed Access | Times Cited: 1
Polyanhydride nanovaccine against H3N2 influenza A virus generates mucosal resident and systemic immunity promoting protection
Christopher E. Lopez, Zeb R. Zacharias, Kathleen A. Ross, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Christopher E. Lopez, Zeb R. Zacharias, Kathleen A. Ross, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Deciphering immune responses: a comparative analysis of influenza vaccination platforms
Charles H. Jones, Teresa Hauguel, Marie Beitelshees, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 9, pp. 104125-104125
Open Access | Times Cited: 1
Charles H. Jones, Teresa Hauguel, Marie Beitelshees, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 9, pp. 104125-104125
Open Access | Times Cited: 1
Targeting H3N2 influenza: advancements in treatment and vaccine strategies
Shriyansh Srivastava, Nandani Jayaswal, Sachin Kumar, et al.
Expert Review of Anti-infective Therapy (2024)
Closed Access | Times Cited: 1
Shriyansh Srivastava, Nandani Jayaswal, Sachin Kumar, et al.
Expert Review of Anti-infective Therapy (2024)
Closed Access | Times Cited: 1
Antigenic switch potential of influenza D virus
Abdul Bari Hejran, Khaidarov Saken, Rahmatullah Afghan, et al.
Asia-Pacific Journal of Pharmacotherapy & Toxicology (2024)
Open Access
Abdul Bari Hejran, Khaidarov Saken, Rahmatullah Afghan, et al.
Asia-Pacific Journal of Pharmacotherapy & Toxicology (2024)
Open Access
Computationally Optimized Hemagglutinin Proteins Adjuvanted with Infectimune® Generate Broadly Protective Antibody Responses in Mice and Ferrets
James D. Allen, Xiaojian Zhang, Jéssica Medina, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1364-1364
Open Access
James D. Allen, Xiaojian Zhang, Jéssica Medina, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1364-1364
Open Access
Global research trends in the relationship between influenza and CD4 + T/CD8 + T cells: A bibliometric analysis
Y. Zong, Hui Li, Yonglong Chang, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access
Y. Zong, Hui Li, Yonglong Chang, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access
Nuevos y viejos aspectos de la gripe
Ivan Sanz‐Muñoz, José Marı́a Eiros Bouza
Medicina Clínica (2023) Vol. 161, Iss. 7, pp. 303-309
Closed Access | Times Cited: 1
Ivan Sanz‐Muñoz, José Marı́a Eiros Bouza
Medicina Clínica (2023) Vol. 161, Iss. 7, pp. 303-309
Closed Access | Times Cited: 1
ΔA146Ply-HA stem protein immunization protects mice against influenza A virus infection and co-infection with Streptococcus pneumoniae
Lian Li, Ting Guo, Yuan Yuan, et al.
Molecular Immunology (2023) Vol. 161, pp. 91-103
Closed Access | Times Cited: 1
Lian Li, Ting Guo, Yuan Yuan, et al.
Molecular Immunology (2023) Vol. 161, pp. 91-103
Closed Access | Times Cited: 1
Old and new aspects of influenza
Ivan Sanz‐Muñoz, José Marı́a Eiros Bouza
Medicina Clínica (English Edition) (2023) Vol. 161, Iss. 7, pp. 303-309
Closed Access | Times Cited: 1
Ivan Sanz‐Muñoz, José Marı́a Eiros Bouza
Medicina Clínica (English Edition) (2023) Vol. 161, Iss. 7, pp. 303-309
Closed Access | Times Cited: 1
Mesenchymal stem cells prevent H7N9 virus infection via rejuvenating immune environment to inhibit immune-overactivity
Yinhua Sun, Shihao Huang, Kaituo Liu, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1870, Iss. 2, pp. 166973-166973
Open Access | Times Cited: 1
Yinhua Sun, Shihao Huang, Kaituo Liu, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1870, Iss. 2, pp. 166973-166973
Open Access | Times Cited: 1
Protective Efficacy of Recombinant Influenza Hemagglutinin Ectodomain Fusions
Nidhi Mittal, Nayanika Sengupta, Sameer Kumar Malladi, et al.
Viruses (2021) Vol. 13, Iss. 9, pp. 1710-1710
Open Access | Times Cited: 3
Nidhi Mittal, Nayanika Sengupta, Sameer Kumar Malladi, et al.
Viruses (2021) Vol. 13, Iss. 9, pp. 1710-1710
Open Access | Times Cited: 3
Impact of vaccination on the epidemiology and prognosis of pneumonia
Carlos M. Luna
Revista Española de Quimioterapia (2022) Vol. 35, Iss. Suppl1, pp. 104-110
Open Access | Times Cited: 2
Carlos M. Luna
Revista Española de Quimioterapia (2022) Vol. 35, Iss. Suppl1, pp. 104-110
Open Access | Times Cited: 2
Development and laboratory production of virus-like immune-stimulating complexes based on saponins and evaluation of their adjuvant potential using mice immunisation with influenza antigens
В. А. Евсеенко, Andrei S. Gudymo, N. V. Danilchenko, et al.
Biological Products Prevention Diagnosis Treatment (2022) Vol. 22, Iss. 2, pp. 170-186
Open Access | Times Cited: 2
В. А. Евсеенко, Andrei S. Gudymo, N. V. Danilchenko, et al.
Biological Products Prevention Diagnosis Treatment (2022) Vol. 22, Iss. 2, pp. 170-186
Open Access | Times Cited: 2
Carbohydrate‐Based Antiviral Vaccines
Adrián Plata, Alberto Fernández‐Tejada
(2023), pp. 73-110
Closed Access
Adrián Plata, Alberto Fernández‐Tejada
(2023), pp. 73-110
Closed Access
J Barberán López, F. Lerma, Fernando Baquero, et al.
Revista Española de Quimioterapia (2022) Vol. 35, Iss. Suppl1
Open Access
